Education
About Us
Working with TipRanks
Follow Us
Hologic (HOLX)
NASDAQ:HOLX
HOLX Stock Chart & Stats
$73.95
$0.05(0.07%)
At close: 4:00 PM EST
$73.95
$0.05(0.07%)
Day’s Range― - ―
52-Week Range$51.90 - $84.39
Previous CloseN/A
Volume386.02K
Average Volume (3M)3.54M
Market Cap
$16.46B
Enterprise Value$15.30B
Total Cash (Recent Filing)$1.88B
Total Debt (Recent Filing)$2.52B
Price to Earnings (P/E)30.7
Beta0.09
Next Earnings
Nov 03, 2025EPS Estimate
1.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.08
Shares Outstanding222,419,280
10 Day Avg. Volume5,954,908
30 Day Avg. Volume3,541,929
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue3.79
Enterprise Value/Gross Profit7.31
Enterprise Value/Ebitda15.19
Forecast
1Y Price Target
$78.00Price Target Upside5.48% Upside
Rating ConsensusHold
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumThe acquisition deal represents a 46% premium to HOLX's closing price prior to media reports about a possible transaction.
Private Equity OwnershipHologic is well-suited for private equity ownership due to multiple independent businesses, strong cash flow generation, and low leverage.
Shareholder ApprovalThe Hologic Board of Directors has unanimously approved the merger and is recommending that shareholders vote in favor of the transaction and adopt the agreement.
Bears Say
Analyst DowngradeAnalysts are downgrading shares to EW-Vol. (from OW-Vol.) and adjusting the price target to $76 (from $78).
Growth ConcernsThe discount in the transaction is warranted since HOLX is growing more slowly than its peers.
Hologic News
HOLX FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest stock price was $51.90 and its highest was $84.39 in the past 12 months.
What is Hologic’s market cap?
Hologic’s market cap is $16.46B.
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is Nov 03, 2025 which is in 6 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on Jul 30, 2025. The company reported $1.08 earnings per share for the quarter, beating the consensus estimate of $1.064 by $0.016.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is 1.1.
How many shares outstanding does Hologic have?
Hologic has 222,419,280 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $1.08 in its last earnings report, beating expectations of $1.064. Following the earnings report the stock price went up 2.832%.
Which hedge fund is a major shareholder of Hologic?
Currently, no hedge funds are holding shares in HOLX
Hologic Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$78.00 (5.48% Upside)
$78.00 (5.48% Upside)
Blogger Sentiment
Bullish
HOLX Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 991.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 4.4%
Last 30 Days ▲ 3.2%
Last 30 Days ▲ 3.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-8.51%
12-Months-Change
Fundamentals
Return on Equity
11.38%
Trailing 12-Months
Asset Growth
-0.94%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. is a global medical technology company primarily focused on women's health. Founded in 1985 and headquartered in Marlborough, Massachusetts, Hologic develops, manufactures, and markets a range of diagnostic, surgical, and medical imaging products. The company's core sectors include breast health, diagnostics, gynecological health, and skeletal health, with flagship products such as 3D mammography systems, molecular diagnostics tests, and surgical instruments designed for minimally invasive procedures.
HOLX Company Deck
HOLX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with strong financial performance and promising developments in the Breast Health and Diagnostics segments. Despite some challenges in specific markets and product lines, the company's strategic initiatives and successful product launches indicate a solid path toward growth.View all HOLX earnings summariesHOLX Revenue Breakdown
44.22% Diagnostics
37.79% Breast Health
15.91% GYN Surgical
2.09% Skeletal Health
HOLX Stock 12 Month Forecast
Average Price Target
$78.00
▲(5.48% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Intuitive Surgical
―
Resmed
―
West Pharmaceutical Services
―
Ownership Overview
1.34% Insiders
31.50% Mutual Funds
0.16% Other Institutional Investors
39.55% Public Companies and
Individual Investors